Carregant...
PRAZOSIN FOR THE TREATMENT OF BEHAVIORAL SYMPTOMS IN ALZHEIMER’S DISEASE PATIENTS WITH AGITATION AND AGGRESSION
OBJECTIVES: Agitation and aggression in Alzheimer’s disease (AD) is a major cause of patient distress, caregiver burden, and institutionalization. Enhanced behavioral responsiveness to central nervous system norepinephrine release may contribute to the pathophysiology of agitation and aggression in...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2842091/ https://ncbi.nlm.nih.gov/pubmed/19700947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JGP.0b013e3181ab8c61 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|